KVUE (Kenvue Inc) Net Profit

Corporate emblem and logo of kenvue.com (KVUE)

Kenvue Inc. generates revenue from the global sale of cosmetics and pharmaceutical products, including well-known brands such as Tylenol and Neutrogena. The GURU.Markets service features a line chart of the company's operating net income, where the latest value is recorded as 1.67. Business efficiency relies on customer trust and the reliability of raw material supplies. Stable demand is sustained by loyalty to Band-Aid brands, even during periods of inflationary pressure.

KVUE (Kenvue) Company Net Income history from 02/21/2024 to 10/30/2026

Financial and market metric breakdowns for Kenvue (KVUE)

- price and consensus price forecast:
Stock Quotes Kenvue Health|KVUE - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Kenvue Health|KVUE - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Kenvue|KVUE - Company Book Value|Market-to-Book Ratio kenvue.com|KVUE - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Kenvue Inc.|KVUE - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Kenvue Inc|KVUE - Company Aggregate Debts|Debts to Book Value Kenvue Health|KVUE - Company Long-Term Debt|Company Short-Term Loans and Borrowings Kenvue|Quick Ratio kenvue.com
- net income and valuation multiples indicators:
KVUE - Net Profit
Fundamental valuation:KVUE Kenvue Health
Flagship merchandise of Kenvue Inc

Kenvue Inc. operates on a colossal scale within the consumer health sector. This indicator captures free cash flow, stripped of accounting assumptions, reflecting the actual efficiency of capital generation. Investors decouple model resilience from market noise by analyzing the stability of operating earnings. Amid logistics disruptions and inflationary pressure on consumers, this metric reveals hidden asset write-downs. By analyzing the company's profit volume, one can assess the business's actual resilience to geopolitical risks.

Main competitors

Net Income Haleon Corp|VRNA (Verona Pharma plc) - Net Profit|Net Profit jyongbio.com|Net Income LGND (Ligand)|AMRX (Amneal Pharmaceuticals, Inc.) - Final Profit|Company Net Income Perrigo Company PRGO|Alvotech Biopharmaceuticals (ALVO) - Company Net Income|LQDA: Net Income|glpg.com - Profit After Payment of Taxes|ANIP: Net Profit|MannKind Corp - Final Profit|AMPH (Amphastar) - Net Profit|Company Net Income Pacira Corp PCRX|Company Net Income ARS Pharmaceuticals (SPRY)|TBPH (theravance.com) - Final Profit|Company Net Income Aquestive Therapeutics, Inc. AQST|Net Profit scPharmaceuticals, Inc. SCPH|Tectonic - Net Profit|Company Net Income Tonix Pharmaceuticals Holding|sxtchina.com (SXTC) - Company Net Income|Company Profit EPRX|Net Income BHST|Company Net Income EXOZ|Net Income ORMP (Oramed Pharmaceuticals)|Net Profit enterabio.com (ENTX)|Net Profit HYFT (MindWalk Holdings)|abvcpharma.com (ABVC) - Company Net Income|CPIX: Net Income|Final Profit QNTM (Quantum BioPharma Ltd.)|FGEN: Net Profit|TELO - Net Financial Result|Company Net Income Rani Therapeutics Holdings|Company Profit SNYR (Synergy CHC Corporation)|Net Profit RLYB|Net Income lexariabioscience.com LEXX|Pulmatrix Corp - Net Income|Net Financial Result Pheton Holdings Limited (PTHL)|APM - Company Net Income|LYRA - Net Profit|IBO (Impact BioMedical Inc) - Net Income|TNFA (TNF Pharmaceuticals, Inc.) - Company Net Income|Net Income YCBD|Net Profit PainReform Corp|Net Profit CYTO|LIPO - Company Net Income|Company Net Income OptiNose OPTN|PIRS (Pieris Pharmaceuticals Inc) - Profit After Tax|Procaps Group SA - Net Profit|Final Profit PTPI (Petros Pharma)|QLI: Net Profit|acelyrin.com (SLRN) - Net Profit|Company Net Income TFF Pharmaceuticals, Inc.